Resistance-Based Multicomponent Training Plus Nutrition Supplementation for Intrinsic Capacity and Disability Risk in Chinese Rural Older Adults
Effect of Resistance-Led Multicomponent Training Combined With Nutritional Supplementation on Intrinsic Capacity and Disability Risk in Chinese Rural Older Adults
研究概览
地位
详细说明
This study aims to determine whether resistance-dominant multicomponent training combined with leucine-enriched whey protein and vitamin D supplementation can improve intrinsic capacity and reduce disability risk in rural Chinese older adults. The study focuses on the locomotion and vitality domains of intrinsic capacity, which are closely related to mobility function, nutritional status, muscle reserves, and the ability to maintain independent daily living.
Eligible participants will be rural community-dwelling adults aged 60 years or older who present at least one of the following risk characteristics: reduced physical performance, low gait speed, nutritional risk, sarcopenia risk, or pre-frailty/frailty. After baseline assessment, participants will be randomly allocated in a 1:1:1:1:1 ratio to one of five study groups: control group, nutrition supplementation group, resistance training group, resistance training plus nutrition supplementation group, and resistance-dominant multicomponent training plus nutrition supplementation group.
The traditional resistance training program will include progressive functional resistance exercises such as chair sit-to-stand, chair-assisted squat, calf raise, elastic-band knee extension, elastic-band hip abduction, elastic-band rowing, wall push-up, and shoulder press. The resistance-dominant multicomponent training program will use resistance training as the core component and will additionally include balance, gait, aerobic, flexibility, and breathing relaxation exercises. Exercise sessions will be conducted three times per week for 12 weeks.
The nutritional supplementation will consist of approximately 20 g/day whey protein, 2.5-3.0 g/day total leucine, and 800-1000 IU/day vitamin D3. The supplement will be administered twice daily. On training days, one dose will be taken within 30 minutes to 2 hours after exercise, and another dose after breakfast. On non-training days, the supplement will be taken after breakfast and dinner.
Outcome assessments will be performed at baseline and at week 12. The primary outcomes are the Short Physical Performance Battery score, FRAIL score, and activities of daily living/instrumental activities of daily living scores. Secondary outcomes include 4-meter gait speed, Timed Up and Go test, five-times sit-to-stand test, 30-second chair stand test, handgrip strength, Mini Nutritional Assessment Short Form score, daily protein intake, serum 25-hydroxyvitamin D, body mass index, calf circumference, appendicular skeletal muscle mass index, and quality of life. Safety outcomes include renal function, blood calcium, falls, musculoskeletal injury, gastrointestinal symptoms, and other adverse events.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Henan
-
Jiaozuo、Henan、中国、454000
- Rural Community Sites in Jiaozuo, Henan
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Aged 60 years or older.
- Rural residents who have lived in the study area for at least 6 months and have no plan for long-term absence during the study period.
- Able to walk independently or with a cane for a short distance.
- Meeting at least one of the following risk characteristics: Short Physical Performance Battery score of 9 or lower, usual gait speed of 0.8 m/s or lower, Mini Nutritional Assessment Short Form score of 11 or lower, SARC-F score of 4 or higher, possible sarcopenia according to the Asian Working Group for Sarcopenia 2019 criteria, or FRAIL score of 1 to 3.
- Able to understand the study requirements and provide written informed consent.
Exclusion Criteria:
- Unstable cardiovascular or cerebrovascular events within the past 6 months.
- Severe uncontrolled hypertension, defined as resting systolic blood pressure of 180 mmHg or higher or diastolic blood pressure of 110 mmHg or higher.
- Severe cognitive impairment that prevents understanding of or cooperation with the study procedures.
- Severe osteoarticular disease or neurological disease affecting exercise safety.
- Severe renal dysfunction, such as estimated glomerular filtration rate lower than 30 mL/min/1.73 m², or considered unsuitable for protein supplementation by the study physician.
- Hypercalcemia, active kidney stones, or contraindications to vitamin D supplementation.
- Allergy to whey protein or any component of the nutritional supplement.
- Regular use of protein powder, beta-hydroxy-beta-methylbutyrate, creatine, or other nutritional supplements that may affect muscle metabolism within the past 3 months.
- Participation in another interventional study.
学习计划
研究是如何设计的？
设计细节
- 主要用途：预防
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
安慰剂比较：Control Group
Participants in this group will receive routine health education and an isocaloric placebo without structured exercise training for 12 weeks.
|
Participants will receive routine health education during the 12-week study period.
The health education will include general advice on healthy aging, physical activity safety, balanced diet, fall prevention, and chronic disease self-management.
Participants will not receive structured exercise training or active nutritional supplementation as part of this intervention.
Participants will receive an isocaloric placebo that is similar to the active nutritional supplement in appearance, taste, packaging, and administration frequency.
The placebo will be administered during the 12-week study period.
|
|
实验性的：Nutrition Supplementation Group
Participants in this group will receive leucine-enriched whey protein and vitamin D supplementation without structured exercise training for 12 weeks.
|
Participants will receive a nutritional supplement containing approximately 20 g/day whey protein, 2.5 to 3.0 g/day total leucine, and 800 to 1000 IU/day vitamin D3.
The supplement will be administered twice daily for 12 weeks.
On training days, one dose will be taken within 30 minutes to 2 hours after exercise, and the other dose will be taken after breakfast.
On non-training days, the supplement will be taken after breakfast and dinner.
|
|
实验性的：Resistance Training Group
Participants in this group will receive supervised progressive resistance training three times per week for 12 weeks and an isocaloric placebo.
|
Participants will receive an isocaloric placebo that is similar to the active nutritional supplement in appearance, taste, packaging, and administration frequency.
The placebo will be administered during the 12-week study period.
Participants will complete supervised progressive resistance training three times per week for 12 weeks, with each session lasting 45 to 60 minutes.
Exercises will include chair sit-to-stand, chair-assisted squat, calf raise, elastic-band knee extension, elastic-band hip abduction, elastic-band rowing, wall push-up, and shoulder press.
Training intensity will progress from RPE 3-4/10 during weeks 1-4, to RPE 5-6/10 during weeks 5-8, and RPE 6-7/10 during weeks 9-12.
|
|
实验性的：Resistance Training Plus Nutrition Group
Participants in this group will receive supervised progressive resistance training three times per week for 12 weeks combined with leucine-enriched whey protein and vitamin D supplementation.
|
Participants will receive a nutritional supplement containing approximately 20 g/day whey protein, 2.5 to 3.0 g/day total leucine, and 800 to 1000 IU/day vitamin D3.
The supplement will be administered twice daily for 12 weeks.
On training days, one dose will be taken within 30 minutes to 2 hours after exercise, and the other dose will be taken after breakfast.
On non-training days, the supplement will be taken after breakfast and dinner.
Participants will complete supervised progressive resistance training three times per week for 12 weeks, with each session lasting 45 to 60 minutes.
Exercises will include chair sit-to-stand, chair-assisted squat, calf raise, elastic-band knee extension, elastic-band hip abduction, elastic-band rowing, wall push-up, and shoulder press.
Training intensity will progress from RPE 3-4/10 during weeks 1-4, to RPE 5-6/10 during weeks 5-8, and RPE 6-7/10 during weeks 9-12.
|
|
实验性的：Resistance-Dominant Multicomponent Training Plus Nutrition Group
Participants in this group will receive supervised resistance-dominant multicomponent training three times per week for 12 weeks combined with leucine-enriched whey protein and vitamin D supplementation.
|
Participants will receive a nutritional supplement containing approximately 20 g/day whey protein, 2.5 to 3.0 g/day total leucine, and 800 to 1000 IU/day vitamin D3.
The supplement will be administered twice daily for 12 weeks.
On training days, one dose will be taken within 30 minutes to 2 hours after exercise, and the other dose will be taken after breakfast.
On non-training days, the supplement will be taken after breakfast and dinner.
Participants will complete supervised resistance-dominant multicomponent training three times per week for 12 weeks, with each session lasting 50 to 65 minutes.
The program will use resistance training as the core component and will also include balance, gait, aerobic, flexibility, and breathing relaxation exercises.
Each session will include approximately 25 to 30 minutes of resistance training, 8 to 10 minutes of balance and gait training, 8 to 10 minutes of aerobic exercise, and 5 minutes of stretching and relaxation.
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change From Baseline in Short Physical Performance Battery Score at Week 12
大体时间：Baseline and Week 12
|
The Short Physical Performance Battery will be used to assess lower-extremity physical performance, including standing balance, 4-meter gait speed, and five-times sit-to-stand performance.
Total scores range from 0 to 12, with higher scores indicating better physical performance.
|
Baseline and Week 12
|
|
Change From Baseline in FRAIL Score at Week 12
大体时间：Baseline and Week 12
|
The FRAIL scale will be used to assess frailty status.
The scale includes fatigue, resistance, ambulation, illness, and loss of weight.
Scores range from 0 to 5, with higher scores indicating greater frailty risk.
|
Baseline and Week 12
|
|
Change From Baseline in Activities of Daily Living Score at Week 12
大体时间：Baseline and Week 12
|
Activities of daily living will be assessed to evaluate basic self-care ability in daily life.
Higher scores indicate better basic daily living function.
|
Baseline and Week 12
|
|
Change From Baseline in Instrumental Activities of Daily Living Score at Week 12
大体时间：Baseline and Week 12
|
Instrumental activities of daily living will be assessed to evaluate more complex daily living abilities.
Higher scores indicate better instrumental daily living function.
|
Baseline and Week 12
|
合作者和调查者
调查人员
- 首席研究员：yongzhao f, PhD、Henan Normal University
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- CUPES-PY-2026520
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)？
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.